Change 5-day change 1-year change 3-year change Capi.($)
+0.16%+1.58% - - 52.02M
-6.60%-8.56%+49.38%+63.51% 65B
-4.09%-0.11%+2.22%+53.15% 51.19B
+0.03%+5.56%+9.10%+69.05% 51.2B
-1.53%+2.70%+30.48%+34.12% 43.93B
-1.34%+4.12%+16.64%+115.13% 41.96B
-5.97%-6.22%+228.95%+454.22% 38.14B
+6.53%+8.02%+16.40%+53.41% 33.24B
-0.90%-10.49%+37.09%-3.70% 25.2B
-2.76%-9.54%-16.58%-9.19% 22.03B
Average -1.65%-1.67%+41.52%+92.19% 41.32B
Weighted average by Cap. -2.30%-1.21%+42.14%+95.51%
Logo Genkyotex SA.
GenKyoTex SA is a France-based company involved in the biotechnology sector. The Company focuses on the development of therapies based on selective inhibition of nicotinamide adenine dinucleotide phosphate oxidase (NOX) enzymes, which cause a range of disease processes, such as fibrosis, inflammation, pain processing, cancer development and neurodegeneration. The Company's pipeline includes GKT831, a NOX inhibitor aimed at primary biliary cholangitis (PBC) and fibrosis; GKT771, a NOX inhibitor mainly aimed at inflammatory pain and angiogenesis, and other NOX inhibitors, which target at central nervous system (CNS), hearing loss and oncology.
Employees
9
  1. Stock Market
  2. Stocks
  3. GKTX Stock